🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To explore the efficacy and safety of pomalidomide and bendamustine with de...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2021-02
Trial ID
NCT04762745
This is a Phase II open label, prospective, multicenter trial designed to a...
Status
Not Yet Recruiting
Location
General Hospital of Athens "Alexandra", Athens, Attica
Start Date
2025-06-20
Trial ID
NCT07019545
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Completed
Location
MBCCOP - University of South Alabama
Start Date
1994-06
Trial ID
NCT00002571
This is a Phase 1, open-label, multicenter study of continuous oral dosing ...
Status
Completed
Location
Research Site
Start Date
2016-06-17
Trial ID
NCT02740985
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growt...
Status
Completed
Location
Haematologisch Onkologische Praxis
Start Date
2005-11
Trial ID
NCT00278421
Treatments Being Tested
Part 1 of this study is a 3-arm, randomized, active-controlled, parallel-gr...
Status
Terminated
Location
Multiple Locations
Start Date
2007-07
Trial ID
NCT00537316
Treatments Being Tested
This is an investigator-initiated (IIS), phase 2, prospective, open-label, ...
Status
Unknown
Location
General Hospital of Athens "Evangelismos"
Start Date
2022-05
Trial ID
NCT05298683
Background: \- Cabozantinib is a drug that slows the growth of blood vesse...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2012-09-07
Trial ID
NCT01683994
Treatments Being Tested
This randomized controlled trial aims to evaluate the safety and efficacy o...
Status
Completed
Location
Federal Government Polyclinic (Postgraduate Medical Institute)
Start Date
2025-03-20
Trial ID
NCT06886230
Treatments Being Tested
The study will investigate the effects of adding carfilzomib to the combina...
Status
Completed
Location
University of Chicago Comprehensive Cancer Center
Start Date
2012-08-13
Trial ID
NCT01665794
Treatments Being Tested